Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, ...

Standard Chartered has appointed Jennifer Lassiter as Head of Digital Assets for Europe and the Americas, based in New York City. She will lead t ...